Repu Technology has established collaborations with domestic healthcare and educational institutions in China. Their research spans joint drug studies, tumor staging mechanisms, comparative genomics of patients at different stages, and drug efficacy. They've also partnered with pharmaceutical companies, notably Betta Pharmaceuticals, for tumor biomarker selection, clinical trials, efficacy monitoring, and companion diagnostics. Additionally, they've collaborated with Wenzhou Medical University to establish the "Wenzhou Medical University Institute of Pharmacogenomics Research" ，and have a strategic partnership with the Zhejiang Provincial Lung Cancer Diagnosis and Treatment.